325 related articles for article (PubMed ID: 30036949)
21. Computational approaches for ligand discovery and design in class-A G protein- coupled receptors.
Rodríguez D; Gutiérrez-de-Terán H
Curr Pharm Des; 2013; 19(12):2216-36. PubMed ID: 23016842
[TBL] [Abstract][Full Text] [Related]
22. GPCRs: What Can We Learn from Molecular Dynamics Simulations?
Velgy N; Hedger G; Biggin PC
Methods Mol Biol; 2018; 1705():133-158. PubMed ID: 29188561
[TBL] [Abstract][Full Text] [Related]
23. Evaluating the performance of MM/PBSA for binding affinity prediction using class A GPCR crystal structures.
Yau MQ; Emtage AL; Chan NJY; Doughty SW; Loo JSE
J Comput Aided Mol Des; 2019 May; 33(5):487-496. PubMed ID: 30989574
[TBL] [Abstract][Full Text] [Related]
24. Opportunities and Challenges in the Discovery of Allosteric Modulators of GPCRs.
Bartuzi D; Kaczor AA; Matosiuk D
Methods Mol Biol; 2018; 1705():297-319. PubMed ID: 29188568
[TBL] [Abstract][Full Text] [Related]
25. Automated discovery of GPCR bioactive ligands.
Raschka S
Curr Opin Struct Biol; 2019 Apr; 55():17-24. PubMed ID: 30909105
[TBL] [Abstract][Full Text] [Related]
26. Modeling small molecule-compound binding to G-protein-coupled receptors.
Vaidehi N; Pease JE; Horuk R
Methods Enzymol; 2009; 460():263-88. PubMed ID: 19446730
[TBL] [Abstract][Full Text] [Related]
27. How Ligands Illuminate GPCR Molecular Pharmacology.
Wacker D; Stevens RC; Roth BL
Cell; 2017 Jul; 170(3):414-427. PubMed ID: 28753422
[TBL] [Abstract][Full Text] [Related]
28. Structural insights into ligand recognition and selectivity for classes A, B, and C GPCRs.
Lee SM; Booe JM; Pioszak AA
Eur J Pharmacol; 2015 Sep; 763(Pt B):196-205. PubMed ID: 25981303
[TBL] [Abstract][Full Text] [Related]
29. A Machine Learning Approach for the Discovery of Ligand-Specific Functional Mechanisms of GPCRs.
Plante A; Shore DM; Morra G; Khelashvili G; Weinstein H
Molecules; 2019 Jun; 24(11):. PubMed ID: 31159491
[TBL] [Abstract][Full Text] [Related]
30. Molecular modeling study on the dynamical structural features of human smoothened receptor and binding mechanism of antagonist LY2940680 by metadynamics simulation and free energy calculation.
Bai Q; Shen Y; Jin N; Liu H; Yao X
Biochim Biophys Acta; 2014 Jul; 1840(7):2128-38. PubMed ID: 24637074
[TBL] [Abstract][Full Text] [Related]
31. Recent Advances and Applications of Molecular Docking to G Protein-Coupled Receptors.
Bartuzi D; Kaczor AA; Targowska-Duda KM; Matosiuk D
Molecules; 2017 Feb; 22(2):. PubMed ID: 28241450
[TBL] [Abstract][Full Text] [Related]
32. Recent Advances in Structure-Based Drug Design Targeting Class A G Protein-Coupled Receptors Utilizing Crystal Structures and Computational Simulations.
Lee Y; Basith S; Choi S
J Med Chem; 2018 Jan; 61(1):1-46. PubMed ID: 28657745
[TBL] [Abstract][Full Text] [Related]
33. Elucidating Ligand-Modulated Conformational Landscape of GPCRs Using Cloud-Computing Approaches.
Shukla D; Lawrenz M; Pande VS
Methods Enzymol; 2015; 557():551-72. PubMed ID: 25950981
[TBL] [Abstract][Full Text] [Related]
34. Methods for Virtual Screening of GPCR Targets: Approaches and Challenges.
Cross JB
Methods Mol Biol; 2018; 1705():233-264. PubMed ID: 29188566
[TBL] [Abstract][Full Text] [Related]
35. Application of Multiscale Simulation Tools on GPCRs. An Example with Angiotensin II Type 1 Receptor.
Erol I; Aksoydan B; Kantarcioglu I; Durdagi S
Methods Mol Biol; 2018; 1824():431-448. PubMed ID: 30039423
[TBL] [Abstract][Full Text] [Related]
36. Dynamics and flexibility of G-protein-coupled receptor conformations and their relevance to drug design.
Vaidehi N
Drug Discov Today; 2010 Nov; 15(21-22):951-7. PubMed ID: 20831898
[TBL] [Abstract][Full Text] [Related]
37. Investigating Small-Molecule Ligand Binding to G Protein-Coupled Receptors with Biased or Unbiased Molecular Dynamics Simulations.
Marino KA; Filizola M
Methods Mol Biol; 2018; 1705():351-364. PubMed ID: 29188572
[TBL] [Abstract][Full Text] [Related]
38. Bridging molecular docking to membrane molecular dynamics to investigate GPCR-ligand recognition: the human A₂A adenosine receptor as a key study.
Sabbadin D; Ciancetta A; Moro S
J Chem Inf Model; 2014 Jan; 54(1):169-83. PubMed ID: 24359090
[TBL] [Abstract][Full Text] [Related]
39. Exploring GPCR-Ligand Interactions with the Fragment Molecular Orbital (FMO) Method.
Chudyk EI; Sarrat L; Aldeghi M; Fedorov DG; Bodkin MJ; James T; Southey M; Robinson R; Morao I; Heifetz A
Methods Mol Biol; 2018; 1705():179-195. PubMed ID: 29188563
[TBL] [Abstract][Full Text] [Related]
40. Community-wide assessment of GPCR structure modelling and ligand docking: GPCR Dock 2008.
Michino M; Abola E; ; Brooks CL; Dixon JS; Moult J; Stevens RC
Nat Rev Drug Discov; 2009 Jun; 8(6):455-63. PubMed ID: 19461661
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
